To more comprehensively evaluate the value of radiomic analysis to predict EGFR mutational status in NSCLC, we developed three radiomic signatures derived from PET images alone, CT images alone and combined PET/CT images. This evidence concerns the gene EGFR and non-small cell lung carcinoma.